Literature DB >> 20594890

Invasive sinonasal disease due to dematiaceous fungi in immunocompromised individuals: case report and review of the literature.

Catherine Derber1, Kara Elam, Gonzalo Bearman.   

Abstract

Invasive dematiaceous fungal sinusitis is an uncommon and aggressive disease in immunocompromised individuals. We report a unique case of invasive Exserohilum sinusitis in a pregnant, immunocompromised woman. After treating the woman with pregnancy-induced aplastic anemia and invasive Exserohilum sinusitis and pulmonary disease, we performed a Medline/PubMed review of invasive dematiaceous fungal sinonasal disease in immunocompromised individuals. Twelve cases of proven and one case of probable invasive sinonasal dematiaceous fungal disease in immunocompromised patients are reported in the English-language literature. The majority of patients had underlying hematological conditions. The crude mortality was high, with over half of the patients dying from presumed complications of the underlying immunosuppression. Successful outcomes were associated with surgical debridement, aggressive antifungal use, and a reduction of immunosuppression. The optimal treatment for immunocompromised patients with invasive dematiaceous fungal disease is not known. The role of newer triazoles, posaconazole and voriconazole, appears promising, however more clinical data are needed. Definitive diagnosis requires tissue biopsy and successful treatment is associated with reduction of immunosuppression, aggressive surgical debulking, and systemic antifungal therapy.
Copyright © 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20594890     DOI: 10.1016/j.ijid.2010.04.003

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  11 in total

1.  Stem cells in microfluidics.

Authors:  Huei-Wen Wu; Chun-Che Lin; Gwo-Bin Lee
Journal:  Biomicrofluidics       Date:  2011-03-30       Impact factor: 2.800

2.  Reflections on the approach to treatment of a mycologic disaster.

Authors:  David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2013-02-05       Impact factor: 5.191

3.  Molecular identification and in vitro response to antifungal drugs of clinical isolates of Exserohilum.

Authors:  Keith Cássia da Cunha; Deanna A Sutton; Josepa Gené; Javier Capilla; Josep Cano; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

4.  Deadly Sphenoid Fungus-Isolated Sphenoid Invasive Fungal Rhinosinusitis: A Case Report.

Authors:  Jason E Gilde; Christopher C Xiao; Victoria A Epstein; Jonathan Liang
Journal:  Perm J       Date:  2017

5.  Invasive rhinosinusitis by Exserohilum rostratum in an immunocompetent child.

Authors:  Ayush Gupta; Immaculata Xess; S C Sharma; Saumyaranjan Mallick
Journal:  BMJ Case Rep       Date:  2014-04-07

6.  Successful Posaconazole Therapy of Disseminated Alternariosis due to Alternaria infectoria in a Heart Transplant Recipient.

Authors:  Pavlina Lyskova; Milos Kubanek; Vit Hubka; Eva Sticova; Ludek Voska; Dana Kautznerova; Miroslav Kolarik; Petr Hamal; Martina Vasakova
Journal:  Mycopathologia       Date:  2016-11-19       Impact factor: 2.574

7.  Multi-locus phylogeny and taxonomy of Exserohilum.

Authors:  M Hernández-Restrepo; H Madrid; Y P Tan; K C da Cunha; J Gené; J Guarro; P W Crous
Journal:  Persoonia       Date:  2018-03-13       Impact factor: 11.051

Review 8.  Pathology of Fungal Rhinosinusitis: A Review.

Authors:  Kathleen T Montone
Journal:  Head Neck Pathol       Date:  2016-02-01

9.  Invasive sino-orbital aspergillosis with brain invasion in an immunocompetent pregnant patient.

Authors:  Hamad M Alsulaiman; Sahar M Elkhamary; Mohammed Alrajeh; Osama Al-Alsheikh; Huda Al-Ghadeer
Journal:  Am J Ophthalmol Case Rep       Date:  2021-09-23

10.  A five-year survey of dematiaceous fungi in a tropical hospital reveals potential opportunistic species.

Authors:  Su Mei Yew; Chai Ling Chan; Kok Wei Lee; Shiang Ling Na; Ruixin Tan; Chee-Choong Hoh; Wai-Yan Yee; Yun Fong Ngeow; Kee Peng Ng
Journal:  PLoS One       Date:  2014-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.